CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs

PartnershipENERGI-F703DFUPositive
AI Analysis

Summary

Energenesis and Taiwan Tanabe signed a development agreement for ENERGI-F703DFU, an investigational topical drug candidate for treating diabetic foot ulcers.

Importance:5/10
Sentiment:
0.30
partnershiptopicaldiabetic foot ulcersdevelopment agreement

Read the original article

Published by Pharmaceutical Technology on August 10, 2026 8:41 AM

Read Original